Anzeige
Mehr »
Freitag, 14.11.2025 - Börsentäglich über 12.000 News
Uranpreis steigt deutlich - Diese Aktie könnte vom neuen US-Atomprogramm profitieren
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40CM8 | ISIN: KYG3314S1066 | Ticker-Symbol: 5UD
Frankfurt
13.11.25 | 08:59
0,364 Euro
0,00 % 0,000
Branche
Gesundheitswesen
Aktienmarkt
ASIEN
1-Jahres-Chart
FANGZHOU INC Chart 1 Jahr
5-Tage-Chart
FANGZHOU INC 5-Tage-Chart

Aktuelle News zur FANGZHOU Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
SaFangzhou Inc.: Fangzhou Awarded "Golden Bull Award" for Leadership in AI-Powered Chronic Disease Management1
07.11.Fangzhou Inc.: Fangzhou, Novo Nordisk Launch Initiative for AI-Powered Diabetes and Weight Management Solutions at CIIE447SHANGHAI, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Fangzhou Inc. ("Fangzhou" or the "Company") (HKEX: 06086), a leading provider of AI-driven Internet healthcare solutions, was invited to the "Boundless...
► Artikel lesen
02.11.Fangzhou Inc.: Fangzhou's "XingJie" LLM Completes Key National Filing, Setting Stage for Further AI-Driven Chronic Care Innovations1
29.10.Fangzhou Inc.: Fangzhou and Fosun Pharma Forge Strategic Alliance to Deliver AI-Powered Psoriasis Management164SHANGHAI, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Fangzhou Inc. ("Fangzhou" or the "Company") (HKEX: 06086), a leader in AI-driven Internet healthcare solutions, and Shanghai Fosun Pharmaceutical (Group)...
► Artikel lesen
26.09.Fangzhou Inc.: Fangzhou's 'XingShi' LLM Featured by Nature News and Xinhua, Showcasing AI Innovation in Chronic Disease Care1
FANGZHOU Aktie jetzt für 0€ handeln
25.09.FANGZHOU JIANKE (06086): 2025 INTERIM REPORT-
18.09.Fangzhou Inc.: Fangzhou Named 'Outstanding Growth Story in Hong Kong Stocks' at China Capital Market Development Forum 20251
18.09.Fangzhou Inc.: Fangzhou Wins Gilead 'Award of Excellence' for AI-Driven Chronic Disease Management13
15.09.FANGZHOU JIANKE (06086): ANNOUNCEMENT MADE PURSUANT TO RULE 13.10 OF THE LISTING RULES-
14.09.Fangzhou Inc.: Fangzhou Unveils "XingShi" LLM to Advance AI-Driven Chronic Disease Management2
10.09.Fangzhou Inc.: Fangzhou and Innovent Biologics Form Strategic Alliance for AI-Powered Weight Management Solutions352SHANGHAI, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in AI-driven Internet healthcare solutions, signed a strategic partnership with Innovent...
► Artikel lesen
03.09.Fangzhou Inc.: Fangzhou Secures 2nd National Science Foundation Project Approval, Deepens AI-Driven Healthcare Research2
27.08.Fangzhou Inc.: Fangzhou Posts Strong 1H Revenue and Profit as Physician Network and User Base Expand349HONG KONG, Aug. 27, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in AI-driven Internet healthcare solutions, reported...
► Artikel lesen
27.08.FANGZHOU JIANKE (06086): INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 20253
15.08.FANGZHOU JIANKE (06086): DATE OF BOARD MEETING-
21.07.Fangzhou and Novo Nordisk link on chronic disease management44
21.07.Fangzhou And Novo Nordisk Collaborate To Combat Chronic Diseases45
18.07.Novo Nordisk, Fangzhou Partner to Tackle Chronic Diseases58
18.07.Fangzhou Inc.: Fangzhou and Novo Nordisk Signed Collaboration Memorandum to Establish a New Ecosystem for Health Management458BEIJING, July 18, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, signed a Memorandum...
► Artikel lesen
19.06.FANGZHOU JIANKE (06086): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON THURSDAY, JUNE 19, 20251
Weiter >>
31 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1